NCT00084773View on ClinicalTrials.gov

Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

January 31, 2007

Study Completion Date

March 31, 2010

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

cetuximab

DRUG

fluorouracil

PROCEDURE

neoadjuvant therapy

RADIATION

radiation therapy

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00084773 - Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer | Biotech Hunter | Biotech Hunter